로살탄의 시장 규모는 향후 몇 년 동안 안정적인 성장세를 보이며 2029년까지 4.6%의 CAGR로 17억 9,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 비용 효율적인 항고혈압제에 대한 수요 증가, 예방 의료에 대한 관심 증가, 생활습관병 유병률 증가, 신흥 시장에서의 의료 접근성 확대, 제네릭 의약품의 지속적인 출시 등의 요인에 기인하는 것으로 보입니다. 이 기간 동안 주요 동향으로는 약물전달의 발전, 복합제 개발, 제제 기술 혁신, 제조 공정 개선, 맞춤형 의료 접근법 개발 등을 꼽을 수 있습니다.
고혈압 유병률의 증가는 가까운 장래에 로사르탄 시장의 확장을 주도할 것으로 예상됩니다. 고혈압은 지속적인 고혈압이 특징이며 심장병, 뇌졸중 및 기타 심각한 건강 문제의 위험을 증가시킵니다. 고혈압의 증가는 종종 소금과 가공 식품이 많은 식습관과 관련이 있으며, 이는 체액 저류를 유발하고 심장에 부담을 증가시킵니다. 로살탄은 혈관을 수축시키는 호르몬인 안지오텐신 II를 차단하여 고혈압 관리에 도움을 줍니다. 이 작용으로 혈관이 이완되고 확장되어 혈압을 낮추고 심장의 부담을 줄입니다. 예를 들어, 미국심장협회의 보고에 따르면 2024년 1월 고혈압으로 인한 사망자 수는 13만 1,454명으로 2021년 12만 4,508명에서 증가했다고 합니다. 이러한 고혈압 유병률의 증가는 로살탄의 수요를 견인하고 있습니다.
로살탄 시장의 주요 기업들은 환자의 순응도를 개선하고 치료 용도를 확대할 수 있는 혁신적인 제품 개발에 주력하고 있습니다. 이러한 혁신적인 제품 중 하나는 로살탄 칼륨 경구 현탁액으로, 정제를 삼키기 어려운 환자를 위해 고안된 로살탄 액상 제제입니다. 2025년 3월, 미국 바이오 제약사 사이언티카 홀딩스는 고혈압 치료, 좌심실 비대를 동반한 고혈압 환자의 뇌졸중 위험 감소, 제2형 당뇨병 환자의 당뇨병성 신질환 관리 제2형 당뇨병 환자의 당뇨병성 신증 관리를 위한 즉시 사용 가능한 액상 제제인 Arbli의 FDA 승인을 받았으며, Arbli는 165mL의 페퍼민트 향이 나는 현탁액(10mg/mL)으로 실온에서 18개월 동안 보관할 수 있는 정확한 투약이 가능하며, 배합제 없이도 정확한 투여가 가능합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·코로나와 회복이 시장에 미치는 영향을 포함한다
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 로사르탄 시장 : PESTEL 분석(정치·사회·기술·환경·법적 요인, 촉진요인, 억제요인)
- 최종 이용 산업 분석
- 세계의 로사르탄 시장 : 성장률 분석
- 세계의 로사르탄 시장 규모·성장률 : 실적치, 2019-2024년
- 세계의 로사르탄 시장 규모·성장률 : 예측치, 2024-2029년, 2034년
- 세계의 로사르탄 시장 : 총유효과 시장(TAM)
제6장 시장 세분화
- 세계의 로사르탄 시장 : 투여 방식별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 정제
- 분말
- 현탁액(서스펜션)
- 세계의 로사르탄 시장 : 조달처별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- CMO(의약품 제조업무수탁 기관)
- 사내
- 세계의 로사르탄 시장 : 유통 채널별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 온라인
- 오프라인
- 세계의 로사르탄 시장 : 용도별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 고혈압
- 뇌졸중
- 당뇨병성 신증
- 기타 용도
- 세계의 로사르탄 시장 : 최종사용자별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 성인
- 소아
- 세계의 로사르탄 시장 : 정제 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 25밀리그램(mg)
- 50밀리그램(mg)
- 100밀리그램(mg)
- 세계의 로사르탄 시장 : 분말 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 25밀리그램(mg)
- 50밀리그램(mg)
- 100밀리그램(mg)
- 세계의 로사르탄 시장 : 현탁액 종류별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 5밀리그램(mg)/5밀리리터(mL)
- 10밀리그램(mg)/5밀리리터(mL)
- 25밀리그램(mg)/5밀리리터(mL)
제7장 지역별·국가별 분석
- 세계의 로사르탄 시장 : 지역별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
- 세계의 로사르탄 시장 : 국가별, 실적치·예측치, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 로사르탄 시장 : 경쟁 구도
- 로사르탄 시장 : 기업 개요
- Viatris Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
- Teva Pharmaceutical Industries Ltd(개요, 제품 및 서비스, 전략, 재무 분석)
- Intas Pharmaceuticals Ltd.(개요, 제품 및 서비스, 전략, 재무 분석)
- Sun Pharmaceutical Industries Ltd.(개요, 제품 및 서비스, 전략, 재무 분석)
- Apotex Inc.(개요, 제품 및 서비스, 전략, 재무 분석)
제31장 기타 주요 기업과 혁신적 기업
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- Cipla Ltd.
- Cadila Pharmaceuticals Ltd.
- Lupin Ltd.
- Zydus Lifesciences Ltd.
- Torrent Pharmaceuticals Ltd.
- Alembic Pharmaceuticals Ltd.
- Vasudha Pharma Chem Ltd.
- Unichem Laboratories Ltd.
- Global Pharma Tek
- Manus Aktteva Biopharma LLP
- Emcure Pharmaceuticals Ltd.
- Wellona Pharma
- JPM Pharma & Chemicals Pvt. Ltd.
제32장 세계 시장 : 경쟁 벤치마킹·대시보드
제33장 주요 기업 인수합병(M&A)
제34장 최근의 시장 동향
제35장 시장 잠재력 높은 나라·부문과 전략
- 로사르탄 시장 : 최신 기회를 제공하는 국가(2029년)
- 로사르탄 시장 : 최신 기회를 제공하는 부문(2029년)
- 로사르탄 시장 : 성장 전략(2029년)
제36장 부록
ksm
Losartan is an angiotensin II receptor blocker (ARB) commonly prescribed to treat high blood pressure and reduce the risk of stroke in patients with hypertension. It works by relaxing blood vessels, which makes it easier for the heart to pump blood. Losartan helps lower blood pressure, improves heart function, and protects kidney health, particularly in patients with diabetes.
The primary forms of losartan dosage include tablets, powder, and suspension. Losartan tablets are convenient, once-daily oral medications used to manage hypertension and diabetic nephropathy. It is sourced from various suppliers, including contract manufacturing organizations and in-house production, and is distributed through both online and offline channels. Losartan is used for a range of conditions, including hypertension, stroke, diabetic nephropathy, and more. It is suitable for use by a variety of end-users, including both adults and pediatrics.
The losartan market research report is one of a series of new reports from The Business Research Company that provides losartan market statistics, including the losartan industry global market size, regional shares, competitors with the losartan market share, detailed losartan market segments, market trends, and opportunities, and any further data you may need to thrive in the losartan industry. This losartan market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The losartan market size has grown steadily in recent years. It will grow from $1.44 billion in 2024 to $1.50 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth during the historic period can be attributed to factors such as the increasing geriatric population, rising healthcare expenditure, a rise in diabetic nephropathy cases, greater awareness of blood pressure management, and the growing adoption of generic ARBs.
The losartan market size is expected to see steady growth in the next few years. It will grow to $1.79 billion in 2029 at a compound annual growth rate (CAGR) of 4.6%. The growth during the forecast period can be attributed to factors such as the increasing demand for cost-effective antihypertensive drugs, a growing focus on preventive healthcare, the rising prevalence of lifestyle-related disorders, expanded healthcare access in emerging markets, and the continuous launch of generic formulations. Key trends during this period include advancements in drug delivery systems, the development of fixed-dose combination therapies, innovation in formulation technologies, improved manufacturing processes, and the development of personalized medicine approaches.
The growing prevalence of hypertension is expected to drive the expansion of the losartan market in the near future. Hypertension, characterized by persistently high blood pressure, increases the risk of heart disease, stroke, and other serious health issues. The rise in hypertension is often linked to diets rich in salt and processed foods, which cause fluid retention and increase the strain on the heart. Losartan helps manage hypertension by blocking angiotensin II, a hormone that narrows blood vessels. This action relaxes and widens the vessels, lowering blood pressure and reducing the heart's burden. For example, the American Heart Association reported that in January 2024, there were 131,454 deaths primarily associated with high blood pressure in 2022, an increase from 124,508 deaths in 2021. This rising prevalence of hypertension is driving the demand for losartan.
Major companies in the losartan market are focusing on creating innovative products to improve patient compliance and expand therapeutic uses. One such innovation is the losartan potassium oral suspension, a liquid form of losartan designed for people who find it difficult to swallow tablets. In March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received FDA approval for Arbli, a ready-to-use liquid formulation for treating hypertension, reducing stroke risk in hypertensive patients with left ventricular hypertrophy, and managing diabetic nephropathy in type 2 diabetes patients. Arbli offers precise dosing without the need for compounding and comes in a 165 mL peppermint-flavored suspension (10 mg/mL), with an 18-month shelf life at room temperature.
In April 2025, Scienture Holdings, Inc. formed a partnership with Saptalis Pharmaceuticals to manufacture Arbli, a losartan potassium oral suspension (10 mg/mL). This collaboration includes warehousing and distribution agreements with strategic partners to ensure the successful market launch of the first FDA-approved ready-to-use oral liquid losartan, addressing the unmet needs in hypertension treatment. Saptalis Pharmaceuticals, based in the United States, is a key partner in this initiative.
Major players in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.
North America was the largest region in the losartan market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in losartan report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the losartan market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The losartan market consists of sales of losartan potassium tablets, losartan-hydrochlorothiazide combination tablets, and generic formulations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Losartan Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on losartan market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for losartan ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The losartan market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Dosage: Tablet; Powder; Suspension
- 2) By Source: Contract Manufacturing Organizations; In-House
- 3) By Distribution Channel: Online; Offline
- 4) By Application: Hypertension; Stroke; Diabetic Nephropathy; Other Applications
- 5) By End-User: Adult; Pediatric
- Subsegments:
- 1) By Tablet: 25 Milligrams (mg); 50 Milligrams (mg); 100 Milligrams (mg)
- 2) By Powder: 25 Milligrams (mg); 50 Milligrams (mg); 100 Milligrams (mg)
- 3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL); 10 Milligrams (mg) Per 5 Milliliters (mL); 25 Milligrams (mg) Per 5 Milliliters (mL)
- Companies Mentioned: Viatris Inc.; Teva Pharmaceutical Industries Ltd; Intas Pharmaceuticals Ltd.; Sun Pharmaceutical Industries Ltd.; Apotex Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Losartan Market Characteristics
3. Losartan Market Trends And Strategies
4. Losartan Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Losartan Growth Analysis And Strategic Analysis Framework
- 5.1. Global Losartan PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Losartan Market Growth Rate Analysis
- 5.4. Global Losartan Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Losartan Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Losartan Total Addressable Market (TAM)
6. Losartan Market Segmentation
- 6.1. Global Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Tablet
- Powder
- Suspension
- 6.2. Global Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Contract Manufacturing Organizations
- In-House
- 6.3. Global Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Online
- Offline
- 6.4. Global Losartan Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hypertension
- Stroke
- Diabetic Nephropathy
- Other Applications
- 6.5. Global Losartan Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Adult
- Pediatric
- 6.6. Global Losartan Market, Sub-Segmentation Of Tablet, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25 Milligrams (mg)
- 50 Milligrams (mg)
- 100 Milligrams (mg)
- 6.7. Global Losartan Market, Sub-Segmentation Of Powder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25 Milligrams (mg)
- 50 Milligrams (mg)
- 100 Milligrams (mg)
- 6.8. Global Losartan Market, Sub-Segmentation Of Suspension, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 5 Milligrams (mg) Per 5 Milliliters (mL)
- 10 Milligrams (mg) Per 5 Milliliters (mL)
- 25 Milligrams (mg) Per 5 Milliliters (mL)
7. Losartan Market Regional And Country Analysis
- 7.1. Global Losartan Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Losartan Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Losartan Market
- 8.1. Asia-Pacific Losartan Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Losartan Market
- 9.1. China Losartan Market Overview
- 9.2. China Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Losartan Market
- 10.1. India Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Losartan Market
- 11.1. Japan Losartan Market Overview
- 11.2. Japan Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Losartan Market
- 12.1. Australia Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Losartan Market
- 13.1. Indonesia Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Losartan Market
- 14.1. South Korea Losartan Market Overview
- 14.2. South Korea Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Losartan Market
- 15.1. Western Europe Losartan Market Overview
- 15.2. Western Europe Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Losartan Market
- 16.1. UK Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Losartan Market
- 17.1. Germany Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Losartan Market
- 18.1. France Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Losartan Market
- 19.1. Italy Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Losartan Market
- 20.1. Spain Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Losartan Market
- 21.1. Eastern Europe Losartan Market Overview
- 21.2. Eastern Europe Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Losartan Market
- 22.1. Russia Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Losartan Market
- 23.1. North America Losartan Market Overview
- 23.2. North America Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Losartan Market
- 24.1. USA Losartan Market Overview
- 24.2. USA Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Losartan Market
- 25.1. Canada Losartan Market Overview
- 25.2. Canada Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Losartan Market
- 26.1. South America Losartan Market Overview
- 26.2. South America Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Losartan Market
- 27.1. Brazil Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Losartan Market
- 28.1. Middle East Losartan Market Overview
- 28.2. Middle East Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Losartan Market
- 29.1. Africa Losartan Market Overview
- 29.2. Africa Losartan Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Losartan Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Losartan Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Losartan Market Competitive Landscape And Company Profiles
- 30.1. Losartan Market Competitive Landscape
- 30.2. Losartan Market Company Profiles
- 30.2.1. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Teva Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Intas Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Apotex Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Losartan Market Other Major And Innovative Companies
- 31.1. Aurobindo Pharma Ltd.
- 31.2. Dr. Reddy's Laboratories Ltd.
- 31.3. Cipla Ltd.
- 31.4. Cadila Pharmaceuticals Ltd.
- 31.5. Lupin Ltd.
- 31.6. Zydus Lifesciences Ltd.
- 31.7. Torrent Pharmaceuticals Ltd.
- 31.8. Alembic Pharmaceuticals Ltd.
- 31.9. Vasudha Pharma Chem Ltd.
- 31.10. Unichem Laboratories Ltd.
- 31.11. Global Pharma Tek
- 31.12. Manus Aktteva Biopharma LLP
- 31.13. Emcure Pharmaceuticals Ltd.
- 31.14. Wellona Pharma
- 31.15. JPM Pharma & Chemicals Pvt. Ltd.
32. Global Losartan Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Losartan Market
34. Recent Developments In The Losartan Market
35. Losartan Market High Potential Countries, Segments and Strategies
- 35.1 Losartan Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Losartan Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Losartan Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
